Press releases

Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as...

With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets,...

Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support DUBLIN and SEONGNAM, South Korea, May 25, 2023 /

Resolution follows the recent FDA approval of the MiniMed™ 780G system featuring the world's first and only automated insulin delivery system with real-time meal detection technology* DUBLIN,...

Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps DUBLIN, April 21, 2023 /PRNewswire/...

A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetes DUBLIN and BERLIN, Feb....

Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set DUBLIN, Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global...

Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's...